Iovance Biotherapeutics, Inc. (IOVA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156214,
    "name": "Iovance Biotherapeutics, Inc.",
    "stock_name": "Iovance Biotherapeutics, Inc.",
    "full_name": "Iovance Biotherapeutics, Inc.",
    "name_url": "stocks-analysis/iovance-biotherapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.20",
    "chg": 0.07,
    "chgp": "3.04%",
    "dir": 1,
    "prev_price": "2.13",
    "mcapval": "861.21",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US4622601007",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.2 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/iovance-biotherapeutics-inc-1156214-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Iovance Biotherapeutics Stock Hits Day Low of $2 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iovance-biotherapeutics-stock-hits-day-low-of-2-amid-price-pressure-3659300",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IovanceBiothera_priceRelatedfactors_3659300.png",
        "date": "2025-10-30 19:27:10",
        "description": "Iovance Biotherapeutics, Inc. faced a notable decline, with its stock reaching an intraday low of USD 2.00. The company has struggled recently, showing a 10.31% decrease over the past month and a 72.97% loss year-to-date, alongside negative financial metrics and reduced promoter confidence."
      },
      {
        "title": "Iovance Biotherapeutics Experiences Revision in Stock Evaluation Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iovance-biotherapeutics-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-decline-3601047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IovanceBiothera_technicaldot_3601047.png",
        "date": "2025-10-07 19:52:39",
        "description": "Iovance Biotherapeutics, Inc. has experienced a stock price decline, currently at $2.21, with a notable 52-week range. Technical indicators show mixed performance, reflecting varied momentum. The company has struggled significantly over the past year, contrasting sharply with the S&P 500's gains, highlighting ongoing market challenges."
      },
      {
        "title": "Is Iovance Biotherapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-iovance-biotherapeutics-inc-technically-bullish-or-bearish-3599253",
        "imagepath": "",
        "date": "2025-10-07 12:22:20",
        "description": "As of 3 October 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly timeframe but is bearish on the monthly. The RSI is bullish on the monthly but shows no signal on the weekly. Moving averages are bearish on the daily, while the KST indicates bullishness weekly but bearishness monthly. The Bollinger Bands are sideways weekly and mildly bearish monthly. \n\nThe stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -70.14% versus the S&P's 14.18%, and a one-year return of -78.87% compared to the S&P's 17.82%...."
      },
      {
        "title": "Is Iovance Biotherapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-iovance-biotherapeutics-inc-technically-bullish-or-bearish-3593979",
        "imagepath": "",
        "date": "2025-10-06 12:12:22",
        "description": "As of 3 October 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a bearish daily moving average and a mildly bearish weekly Dow Theory. The MACD shows a mildly bullish signal on the weekly but remains bearish on the monthly, while the RSI indicates a bullish monthly signal with no signal on the weekly. The Bollinger Bands are bullish on the weekly but mildly bearish on the monthly, and the KST is bullish weekly but bearish monthly. \n\nIn terms of performance, the stock has returned -68.38% year-to-date compared to a 14.18% gain in the S&P 500, highlighting significant underperformance over the longer term as well...."
      },
      {
        "title": "Is Iovance Biotherapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-iovance-biotherapeutics-inc-technically-bullish-or-bearish-3592053",
        "imagepath": "",
        "date": "2025-10-05 11:57:38",
        "description": "As of 3 October 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals: the MACD is mildly bullish on a weekly basis but bearish monthly, while the RSI is bullish monthly but has no signal weekly. The Bollinger Bands indicate a bullish weekly trend but a mildly bearish monthly trend. Moving averages are bearish on a daily basis, and the KST is bullish weekly but bearish monthly. The Dow Theory shows a mildly bearish trend weekly with no trend monthly. \n\nIn terms of performance, the stock has returned 10.90% over the past week and 5.88% over the past month, outperforming the S&P 500 in those periods, which returned 1.09% and 4.15%, respectively. However, the longer-term returns are significantly negative, with a year-to-date return of -68.38% compared to the S&P 500's 14.18%...."
      },
      {
        "title": "Iovance Biotherapeutics Experiences Revision in Stock Evaluation Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iovance-biotherapeutics-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-decline-3559559",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/IovanceBiothera_technicaldot_3559559.png",
        "date": "2025-09-23 16:01:19",
        "description": "Iovance Biotherapeutics, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock price is currently $2.12, reflecting notable volatility over the past year. Technical indicators present mixed signals, and the company's performance has significantly lagged behind the S&P 500, underscoring ongoing challenges."
      },
      {
        "title": "Is Iovance Biotherapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-iovance-biotherapeutics-inc-technically-bullish-or-bearish-3558421",
        "imagepath": "",
        "date": "2025-09-23 11:21:14",
        "description": "As of 19 September 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and monthly MACD being bearish. The weekly MACD shows a mildly bullish signal, but this is overshadowed by the bearish signals from the Bollinger Bands and KST on a monthly basis. The stock has underperformed significantly compared to the S&P 500 across all multi-period returns, with a year-to-date return of -71.35% versus the S&P 500's 13.31%...."
      },
      {
        "title": "Is Iovance Biotherapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-iovance-biotherapeutics-inc-technically-bullish-or-bearish-3552281",
        "imagepath": "",
        "date": "2025-09-22 18:07:16",
        "description": "As of 19 September 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with a weak strength indicated by the daily moving averages and the overall bearish signals from the Bollinger Bands. The MACD shows a mildly bullish signal on the weekly timeframe but remains bearish on the monthly. The KST is bullish weekly but bearish monthly, while the Dow Theory indicates a mildly bearish stance on the weekly timeframe. \n\nIn terms of performance, Iovance has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -72.30% compared to the S&P 500's 13.31%, and a one-year return of -80.19% against the S&P 500's 16.64%...."
      },
      {
        "title": "Is Iovance Biotherapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-iovance-biotherapeutics-inc-technically-bullish-or-bearish-3547105",
        "imagepath": "",
        "date": "2025-09-20 19:47:08",
        "description": "As of 5 September 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD is mildly bullish on the weekly timeframe but bearish on the monthly, while Bollinger Bands show a mildly bullish signal weekly and bearish monthly. The daily moving averages are bearish, and the KST is bullish weekly but bearish monthly. Additionally, the OBV is mildly bearish on the weekly timeframe. \n\nThe stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -70.27% versus the S&P 500's 12.22%, and a one-year return of -78.37% compared to the S&P 500's 17.14%...."
      }
    ],
    "total": 15,
    "sid": "1156214",
    "stock_news_url": "https://www.marketsmojo.com/news/iovance-biotherapeutics-inc-1156214"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Iovance Biotherapeutics Stock Hits Day Low of $2 Amid Price Pressure

2025-10-30 19:27:10

Iovance Biotherapeutics, Inc. faced a notable decline, with its stock reaching an intraday low of USD 2.00. The company has struggled recently, showing a 10.31% decrease over the past month and a 72.97% loss year-to-date, alongside negative financial metrics and reduced promoter confidence.

Iovance Biotherapeutics Experiences Revision in Stock Evaluation Amid Market Challenges

2025-10-07 19:52:39

Iovance Biotherapeutics, Inc. has experienced a stock price decline, currently at $2.21, with a notable 52-week range. Technical indicators show mixed performance, reflecting varied momentum. The company has struggled significantly over the past year, contrasting sharply with the S&P 500's gains, highlighting ongoing market challenges.

Is Iovance Biotherapeutics, Inc. technically bullish or bearish?

2025-10-07 12:22:20

As of 3 October 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD shows a mildly bullish signal on the weekly timeframe but is bearish on the monthly. The RSI is bullish on the monthly but shows no signal on the weekly. Moving averages are bearish on the daily, while the KST indicates bullishness weekly but bearishness monthly. The Bollinger Bands are sideways weekly and mildly bearish monthly. The stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -70.14% versus the S&P's 14.18%, and a one-year return of -78.87% compared to the S&P's 17.82%....

Is Iovance Biotherapeutics, Inc. technically bullish or bearish?

2025-10-06 12:12:22

As of 3 October 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a bearish daily moving average and a mildly bearish weekly Dow Theory. The MACD shows a mildly bullish signal on the weekly but remains bearish on the monthly, while the RSI indicates a bullish monthly signal with no signal on the weekly. The Bollinger Bands are bullish on the weekly but mildly bearish on the monthly, and the KST is bullish weekly but bearish monthly. In terms of performance, the stock has returned -68.38% year-to-date compared to a 14.18% gain in the S&P 500, highlighting significant underperformance over the longer term as well....

Is Iovance Biotherapeutics, Inc. technically bullish or bearish?

2025-10-05 11:57:38

As of 3 October 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals: the MACD is mildly bullish on a weekly basis but bearish monthly, while the RSI is bullish monthly but has no signal weekly. The Bollinger Bands indicate a bullish weekly trend but a mildly bearish monthly trend. Moving averages are bearish on a daily basis, and the KST is bullish weekly but bearish monthly. The Dow Theory shows a mildly bearish trend weekly with no trend monthly. In terms of performance, the stock has returned 10.90% over the past week and 5.88% over the past month, outperforming the S&P 500 in those periods, which returned 1.09% and 4.15%, respectively. However, the longer-term returns are significantly negative, with a year-to-date return of -68.38% compared to the S&P 500's 14.18%....

Iovance Biotherapeutics Experiences Revision in Stock Evaluation Amid Market Volatility

2025-09-23 16:01:19

Iovance Biotherapeutics, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock price is currently $2.12, reflecting notable volatility over the past year. Technical indicators present mixed signals, and the company's performance has significantly lagged behind the S&P 500, underscoring ongoing challenges.

Is Iovance Biotherapeutics, Inc. technically bullish or bearish?

2025-09-23 11:21:14

As of 19 September 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and monthly MACD being bearish. The weekly MACD shows a mildly bullish signal, but this is overshadowed by the bearish signals from the Bollinger Bands and KST on a monthly basis. The stock has underperformed significantly compared to the S&P 500 across all multi-period returns, with a year-to-date return of -71.35% versus the S&P 500's 13.31%....

Is Iovance Biotherapeutics, Inc. technically bullish or bearish?

2025-09-22 18:07:16

As of 19 September 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with a weak strength indicated by the daily moving averages and the overall bearish signals from the Bollinger Bands. The MACD shows a mildly bullish signal on the weekly timeframe but remains bearish on the monthly. The KST is bullish weekly but bearish monthly, while the Dow Theory indicates a mildly bearish stance on the weekly timeframe. In terms of performance, Iovance has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -72.30% compared to the S&P 500's 13.31%, and a one-year return of -80.19% against the S&P 500's 16.64%....

Is Iovance Biotherapeutics, Inc. technically bullish or bearish?

2025-09-20 19:47:08

As of 5 September 2025, the technical trend for Iovance Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD is mildly bullish on the weekly timeframe but bearish on the monthly, while Bollinger Bands show a mildly bullish signal weekly and bearish monthly. The daily moving averages are bearish, and the KST is bullish weekly but bearish monthly. Additionally, the OBV is mildly bearish on the weekly timeframe. The stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -70.27% versus the S&P 500's 12.22%, and a one-year return of -78.37% compared to the S&P 500's 17.14%....

View All News